Startups
Cynvenio Biosystems, Inc. is an emerging leader in the development of more affordable and clinically actionable precision medicine strategies for the individual cancer patient. Focused on rapid advancement in the molecular biology field, Cynvenio’s genomic tests accurately target known mutations in cancer-related genes to revolutionize personalized treatment decision making and clinical trial selection.
Among its breakthroughs is an expanding line of ClearID® tests engineered for greatly improved cancer detection and monitoring via a patient-friendly blood draw, and proprietary LiquidBiopsy® technology that makes real-time molecular characterization from whole blood a reality.
Cynvenio is based in Westlake Village, CA (Los Angeles). For more information, please visit www.cynvenio.com or www.clearidmonitoring.com.
Among its breakthroughs is an expanding line of ClearID® tests engineered for greatly improved cancer detection and monitoring via a patient-friendly blood draw, and proprietary LiquidBiopsy® technology that makes real-time molecular characterization from whole blood a reality.
Cynvenio is based in Westlake Village, CA (Los Angeles). For more information, please visit www.cynvenio.com or www.clearidmonitoring.com.
Overview
Phone
+1 888-885-1172
Total raised
$27.5M
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Feb 7, 2012 | Funding round | $2M |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 17, 2015 | Cynvenio Biosystems Finds $25.5M More For Cancer Diagnostics | Westlake Village-based Cynvenio Biosystems said Wednesday that it has raised $25.5M in a Series B funding round. The developer of life sciences equipment, used to profile cancer cells circulating in whole blood, came from Livzon Pharmaceuti... |
| Jun 5, 2015 | Cancer diagnostics maker Cynvenio Biosystems raises $25.5M | To provide cancer diagnostics, it extracts and isolates circulating tumor cells from the blood, then performs high throughput genomic analysis – a project it’s actually working on with Thermo Fisher Scientific. The funding will be used as w... |
| Feb 7, 2012 | Cynvenio Biosystems Raises $2.0M, Gets NCI Contracts | Westlake Village-based Cynvenio Biosystems, which is developing molecular diagnostics systems for cancer, announced this morning that it has received $2.0M in financing, plus scored two Small Business Innovative Research (SBIR) contracts fr... |
| Jan 11, 2010 | Cynvenio Biosystems Gets Nearly $2M | Westlake Village-based Cynvenio Biosystems, a developer of high speed, bioseparation instruments for the life sciences market, has raised $1.96M in a Series B funding round, according to a regulatory filing by the firm today. Source of the ... |
| Cancer diagnostics maker Cynvenio Biosystems raises $25.5M | Los Angeles cancer diagnostics maker Cynvenio Biosystems just raised $25.5 million, according to a regulatory filing. The company’s been positioning itself as a contender in the precision medicine game – helping physicians navigate cancer t... |
Reviews 0
FAQ about Cynvenio Biosystems, Inc.
How much funding has Cynvenio Biosystems, Inc. raised?
Cynvenio Biosystems, Inc. has raised $27.5M in total across 2 funding rounds.
What funding rounds has Cynvenio Biosystems, Inc. raised?
Parsers VC lists 2 funding rounds of Cynvenio Biosystems, Inc., among them a funding round of $2M on Feb 7, 2012.
What has the press written about Cynvenio Biosystems, Inc.?
Parsers VC has collected 6 articles mentioning Cynvenio Biosystems, Inc., among them “Cynvenio Biosystems Finds $25.5M More For Cancer Diagnostics” (Jun 17, 2015) and “Cancer diagnostics maker Cynvenio Biosystems raises $25.5M” (Jun 5, 2015).
Is Cynvenio Biosystems, Inc. still active?
Cynvenio Biosystems, Inc. is probably closed: its latest activity on Parsers VC dates from Jun 18, 2015.